華章科技(01673.HK)延發全年度業績 今早起停牌
華章科技(01673.HK)公布,由於第五波新冠疫情及集團相關會計人員受到感染,加上內地若干城市實施旅遊管制及隔離措施的影響,集團2022年全年業績的審核程序受到不利影響,並需要額外時間完成審核程序,包括若干審核確認書的擔保及答覆。基於上述理由,公司核數師無法如期完成所有審核工作,而公司將無法根據聯交所證券上市規則,於9月30日或之前刊發2022年全年業績。
公司正與核數師緊密合作,並已應要求提供必要資料及文件,以便核數師盡快完成審核工作。公司將須與核數師進一步商定2022年全年業績的預期刊發日期。公司將在適當時候另行刊發公告。
公司股份今日(3日)上午9時正起暫停在聯交所買賣,直至刊發有關2022年全年業績的公告為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.